IC
Ikarian Capital Portfolio holdings
AUM
$302M
1-Year Est. Return
65.21%
1 Year Est. Return
+65.21%
AUM
$302M
AUM Growth
-$4.71M
(-1.5%)
Holding
160
Top Buys
| 1 | +$10.5M | |
| 2 | +$10.1M | |
| 3 | +$8.15M | |
| 4 |
Insmed
INSM
|
+$7.95M |
| 5 |
Cogent Biosciences
COGT
|
+$7.44M |
Top Sells
| 1 | +$14M | |
| 2 | +$11.7M | |
| 3 | +$10.1M | |
| 4 |
Ultragenyx Pharmaceutical
RARE
|
+$7.86M |
| 5 |
Scholar Rock
SRRK
|
+$6.91M |
Sector Composition
| 1 | Healthcare | 99.76% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Teladoc Health
TDOC
$1.51B
| – | – |
-150,000
|
|
||
152
Teva Pharmaceuticals
TEVA
$22.2B
| – | – |
0
|
|
||
|
THRD
153
DELISTED
Third Harmonic Bio
THRD
| – | – |
-100,000
|
|
||
154
Trupanion
TRUP
$1.84B
| – | – |
0
|
|
||
155
Trevi Therapeutics
TRVI
$1.26B
| – | – |
-575,000
|
|
||
156
Tyra Biosciences
TYRA
$773M
| – | – |
-35,000
|
|
||
|
VERV
157
DELISTED
Verve Therapeutics
VERV
| – | – |
-358,393
|
|
||
|
PTHS
158
Pelthos Therapeutics
PTHS
$89M
| – | – |
-44,085
|
|
||
|
CLYM
159
Climb Bio
CLYM
$131M
| – | – |
-175,088
|
|
||
|
OKUR
160
OnKure Therapeutics
OKUR
$37.6M
| – | – |
-253,754
|
|